Protagonist Therapeutics, Inc. Share Price
Stocks
PTGX
US74366E1029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 16/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 143.40 USD | -2.96% |
|
-1.74% | +64.19% |
| Market Cap | 927.92Cr 803.76Cr 760.04Cr 688.09Cr 1.29TCr 89TCr 1.3TCr 9.07TCr 3.49TCr 45TCr 3.49TCr 3.41TCr 1,43900Cr | P/E 2026 * |
30.8x | P/E 2027 * | -302x |
|---|---|---|---|---|---|
| Enterprise Value | 874.09Cr 757.14Cr 715.95Cr 648.17Cr 1.22TCr 84TCr 1.23TCr 8.54TCr 3.29TCr 43TCr 3.28TCr 3.21TCr 1,35600Cr | EV / Sales 2026 * |
16.1x | EV / Sales 2027 * | 43.1x |
| Free-Float |
97.68% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTGX | Delayed | |
CBOE
| PTGX | Real-time | |
|
Tradegate
| PGF | Real-time |
Last Transcript: Protagonist Therapeutics, Inc.
| 1 day | -2.96% | ||
| 1 week | -1.74% | ||
| Current month | -2.94% | ||
| 1 month | -7.54% | ||
| 3 months | +27.51% | ||
| 6 months | +55.26% | ||
| Current year | +64.19% |
| 1 week | 142 |  | 151.24 |
| 1 month | 141.95 | | 160.81 |
| Current year | 77 | | 160.81 |
| 1 year | 58.91 | | 160.81 |
| 3 years | 13.72 | | 160.81 |
| 5 years | 6.91 | | 160.81 |
| 10 years | 4.47 | | 160.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 69 | 01/12/2008 |
Asif Ali
DFI | Director of Finance/CFO | 52 | 18/04/2022 |
Venkat Thalladi
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Dinesh Patel
BRD | Director/Board Member | 69 | 01/12/2008 |
Harold Selick
CHM | Chairman | 71 | 19/03/2014 |
William Waddill
BRD | Director/Board Member | 69 | 01/07/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/09/26 | Exercice | Chief Executive Officer | 21,834 | 0.0337% | ||
| 03/09/26 | Don | Chief Executive Officer | -510 | 0.0008% | ||
| 11/08/26 | Exercice | Chief Executive Officer | 1,02,717 | 0.1597% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.96% | -1.74% | +145.63% | +701.12% | 927.92Cr | |
| +0.56% | -3.38% | -1.83% | +8.00% | 4.58TCr | |
| -0.12% | -1.19% | +343.42% | +545.03% | 4.39TCr | |
| +1.51% | +4.04% | +45.01% | +27.38% | 4.44TCr | |
| -2.07% | -1.42% | +4.28% | +72.97% | 3.94TCr | |
| -0.73% | -3.06% | +9.63% | +38.92% | 3.13TCr | |
| -9.49% | -11.23% | - | - | 1.57TCr | |
| +4.21% | +5.01% | +24.99% | +121.62% | 1.73TCr | |
| +1.83% | +3.20% | +16.49% | +32.73% | 1.47TCr | |
| -0.08% | -2.81% | +79.24% | +31.27% | 1.3TCr | |
| Average | -0.73% | -1.26% | +74.10% | +175.45% | 2.75TCr | |
| Weighted average by Cap. | -0.35% | -1.25% | +79.20% | +150.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 54Cr 47Cr 44Cr 40Cr 75Cr 5.2TCr 76Cr 530.04Cr 203.92Cr 2.64TCr 203.69Cr 199.18Cr 8.41TCr | 20Cr 18Cr 17Cr 15Cr 28Cr 1.95TCr 29Cr 198.82Cr 76Cr 989.38Cr 76Cr 75Cr 3.16TCr |
| Net income | 32Cr 28Cr 27Cr 24Cr 45Cr 3.11TCr 45Cr 316.46Cr 121.75Cr 1.57TCr 121.62Cr 118.92Cr 5.02TCr | -3.21Cr -2.78Cr -2.63Cr -2.38Cr -4.47Cr -308.13Cr -4.5Cr -31Cr -12Cr -156.24Cr -12Cr -12Cr -498.27Cr |
| Net Debt | -54Cr -47Cr -44Cr -40Cr -75Cr -5.16TCr -75Cr -526.11Cr -202.41Cr -2.62TCr -202.18Cr -197.7Cr -8.35TCr | -51Cr -44Cr -42Cr -38Cr -71Cr -4.9TCr -72Cr -499.56Cr -192.19Cr -2.49TCr -191.98Cr -187.72Cr -7.93TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | $143.40 | -2.96% | 6,37,522 |
| 14/26/14 | $147.78 | -0.27% | 6,08,017 |
| 11/26/11 | $148.18 | +2.08% | 4,78,038 |
| 10/26/10 | $145.16 | +0.05% | 5,43,129 |
| 09/26/09 | $145.09 | -0.58% | 5,30,534 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PTGX Stock
Select your edition
All financial news and data tailored to specific country editions
